Sponsored in part by Servier Pharmaceuticals. Content independently developed by OncLive.
EP. 4: Genomics Guide Treatment, But Novel Agents Generate Excitement in AML and HR-MDS
April 28th 2022New data ranging from up-front approaches with targeted therapy to maintenance therapy, as well as emerging findings with novel agents continue to push the paradigm forward in acute myeloid leukemia and higher-risk myelodysplastic syndromes.